A

Arrowhead Pharmaceuticals

Develops RNAi-based gene-silencing therapies

Associate Director - External Manufacturing

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeVerona, WI, USA$150k - $170k

About the Job

Requirements

  • A PhD, M.S., or B.S. in Chemistry, Chemical Engineering, Biochemistry, Pharmaceutical Sciences, or a related discipline.
  • At least 8 years of experience in biopharmaceutical technical operations, external manufacturing, or CMC, with progressive responsibility; fewer years may be acceptable for PhD candidates.
  • Demonstrated success directly managing CDMO relationships as the primary technical/business owner, including technology transfer, GMP manufacturing oversight, and performance management.
  • Direct experience with synthetic oligonucleotide (siRNA or ASO) manufacturing.
  • Proven ability to lead and influence in a highly matrixed, cross-functional environment spanning Process Development, Analytical Development, Quality, Regulatory, and Supply Chain.
  • Experience supporting late-stage clinical programs and/or commercial launches, including PPQ and BLA/NDA-supporting activities.
  • Strong working knowledge of FDA, EMA, and ICH GMP requirements, and experience supporting regulatory inspections at CDMOs.
  • Ability to translate technical detail into executive-level recommendations through written and verbal communication.
  • Current, valid authorization to work in the country where the role is located.

Responsibilities

  • Serve as the single point of accountability and primary technical/business interface for an assigned portfolio of 1–3 strategic CDMOs supporting drug substance, conjugation, and/or drug product manufacturing.
  • Own day-to-day operational relationships by leading joint operating cadences, governance meetings, escalation pathways, and performance reviews, and cultivating partnerships with CDMO leadership and technical teams.
  • Drive on-time, in-full, in-specification delivery of clinical and commercial supply; monitor and report key performance indicators including yield, cycle time, right-first-time, deviation rate, and on-time release.
  • Lead and approve technology transfers from internal Process Development into the assigned CDMO network, ensuring readiness, documentation, and successful demonstration runs.
  • Review and approve batch records, deviations, CAPAs, change controls, investigations, risk assessments, and validation documentation generated at assigned CDMOs.
  • Develop and execute risk mitigation strategies for critical raw materials, including phosphoramidites, linkers, solid supports, and excipients, as well as secondary sourcing and capacity contingency.
  • Partner with Procurement and Legal on commercial terms, statements of work, quality agreements, and capacity reservations for assigned CDMOs.
  • Act as the connective tissue between assigned CDMOs and internal Process Development, Analytical Development, Quality Assurance, Quality Control, Regulatory Affairs, Supply Chain, Program Management, and Clinical Supply functions.
  • Represent External Manufacturing on cross-functional program teams; translate program priorities into clear CDMO deliverables and CDMO realities into actionable internal decisions.
  • Lead through influence in a matrixed environment by driving alignment, surfacing trade-offs, and resolving conflict without relying on direct authority.
  • Facilitate timely, transparent communication across functions and with CDMO partners so stakeholders have the information needed to make sound, fast decisions.
  • Anticipate and remove cross-functional roadblocks; proactively manage handoffs between Process Development, Analytical Development, Quality Assurance, Regulatory, and Supply Chain to keep manufacturing campaigns on track.
  • Build coalitions around supply strategy, risk decisions, and continuous improvement initiatives, ensuring every functional voice is represented and heard.
  • Provide technical oversight of solid-phase oligonucleotide synthesis, purification using HPLC and TFF/UF-DF, lyophilization, and associated unit operations at assigned CDMOs.
  • Oversee ligand conjugation processes, including GalNAc, and/or other targeted delivery chemistries executed externally.
  • Support drug product formulation, sterile filtration, fill-finish, and stability programs at assigned partners.
  • Ensure assigned CDMO operations align with platform scalability, comparability, and lifecycle management goals.
  • Maintain rigorous control of critical quality attributes, including oligonucleotide purity and impurity profiles (n-1, n+1 species), residual solvents and reagents, conjugation efficiency, potency, and stability.
  • Lead process performance qualification (PPQ), validation, and commercial supply readiness activities at assigned CDMOs.
  • Support comparability assessments for process changes, site transfers, or scale increases.
  • Partner with Supply Chain on demand planning, capacity modeling, and S&OP execution for a growing pipeline.
  • Drive cost-of-goods optimization and continuous improvement initiatives with assigned CDMOs to support long-term commercial strategy.
  • Contribute to CMC sections for INDs, CTAs, BLAs/NDAs, and global regulatory submissions related to assigned CDMOs and products.
  • Support regulatory agency interactions, pre-approval inspections, and ongoing inspection readiness at assigned external manufacturing sites.
  • Partner with Quality Assurance on quality agreements, audit programs, and remediation planning for assigned CDMOs.
  • Champion a culture of compliance, data integrity, and continuous improvement across the external manufacturing network.

Desired Qualifications

  • Experience with GalNAc conjugates or other targeted RNA delivery technologies.
  • Ability to lead and coordinate large, complex strategy projects with minimal direction.
  • Experience developing operations network strategies for a growing global market.

About the Company

Arrowhead Pharmaceuticals

Develops RNAi-based gene-silencing therapies

Arrowhead Pharmaceuticals develops medicines using RNA interference (RNAi) to silence disease-causing genes. The company’s approach uses a library of RNA chemistries and delivery methods to trigger RNAi, enabling rapid and durable reduction of target gene expression in cells. This gene-silencing strategy aims to treat severe genetic diseases such as cystic fibrosis and hepatitis B by lowering disease-related proteins. Arrowhead’s products are advanced through discovery and development partnerships, licensing deals, and potential commercialization of approved therapies. The company differentiates itself through a broad RNAi platform, proprietary delivery tech, and collaborations with larger pharma firms to advance its pipeline. Its goal is to provide new treatment options for conditions with limited or no effective therapies by translating gene silencing into medicines that can halt or reverse disease progression.

Company size
501-1,000
Company stage
IPO
Headquarters
Pasadena, CA
Founded
2004

Recently Posted Jobs

Explore more opportunities at Arrowhead Pharmaceuticals

See more jobs